OPTN antibody (AA 71-96) (HRP)

Catalog No. ABIN1919461

Product Details anti-OPTN Antibody (HRP)

Target: OPTN (Optineurin (OPTN))

Binding Specificity: AA 71-96

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This OPTN antibody is conjugated to HRP

Application: Western Blotting (WB), ELISA

Specificity: This OPTN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 71-96 amino acids from the Central region of human OPTN.

Purification: Protein A purified

Isotype: IgG

Application Details

Application Notes: Approved: ELISA, WB

Usage: The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS, no preservatives added

Preservative: Without preservative

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: 4 °C,-20 °C

Storage Comment: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Expiry Date: 6 months

Target Details for OPTN

Target: OPTN (Optineurin (OPTN))

Alternative Name: OPTN / Optineurin (OPTN Products)

Synonyms: nrp antibody, fip2 antibody, hip7 antibody, hypl antibody, glc1e antibody, tfiiia-intp antibody, ALS12 antibody, FIP2 antibody, GLC1E antibody, HIP7 antibody, HYPL antibody, NRP antibody, TFIIIA-INTP antibody, Fip2 antibody, 4930441O07Rik antibody, fj52f04 antibody, si:ch211-240l19.3 antibody, wu:fj52f04 antibody, zgc:66386 antibody, zgc:77868 antibody, optineurin antibody, optineurin L homeolog antibody, OPTN antibody, optn antibody, Optn antibody, optn.L antibody

Background: Name/Gene ID: OPTN

Synonyms: OPTN, ALS12, E3-14.7K-interacting protein, FIP-2, HIP-7, HYPL, Huntingtin yeast partner L, HIP7, TFIIIA-INTP, NEMO-related protein, NRP, Optineurin, FIP2, GLC1E

Gene ID: 10133

Pathways: M Phase